Skip to main navigation
Skip to content
  • News
  • Careers
  • Open Positions
C4 Therapeutics C4 Therapeutics
  • About Us Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science Expand
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Pipeline
  • Investors Expand
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
C4 Therapeutics

Event Details

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ
Menu

    Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Contact IR
  • FAQ

Virtual Guggenheim Targeted Protein Degradation Day

March 16, 2022 at 8:45 AM EDT

Click here for Webcast

Toolkit

Linkedin-in
Twitter
Phone

617-231-0700

Location

490 Arsenal Way, Suite 120 Watertown, MA 02472

Email

info@c4therapeutics.com

© 2023 C4 Therapeutics, Inc.
Privacy Policy       Terms of Use Agreement        Sitemap
Scroll to top
Search
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
    • Partnerships & Collaborations
    • Quality Policy Statement
  • Our Science
    • Overview
    • Targeted Protein Degradation
    • C4T TORPEDO™ Platform
    • aTAG Open Source Program
    • Scientific Publications
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific Publications
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Email Alerts
    • Contact IR
    • FAQ
  • News
  • Careers
  • Open Positions

Search